Literature DB >> 11803468

Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.

G Hossein Ashrafi1, Emmanouella Tsirimonaki, Barbara Marchetti, Philippa M O'Brien, Gary J Sibbet, Linda Andrew, M Saveria Campo.   

Abstract

The papillomavirus E5 protein is localized in the endoplasmic reticulum (ER) and Golgi apparatus (GA) of the host cell. Transformed bovine fibroblasts expressing bovine papillomavirus (BPV) E5 are highly vacuolated and have a much enlarged, distorted and fragmented GA. Major histocompatibility complex class I (MHC I) is processed and transported to the cell surface through the GA. Given the cellular localization of E5 in the GA and the morphologically abnormal GA, we investigated the expression of MHC I in cells transformed by E5 from BPV-1 and BPV-4. Two cell lines were used: bovine cells that also express E6, E7 and activated ras, and NIH3T3 cells that express only E5. In addition, PalF cells acutely infected with a recombinant retrovirus expressing E5 were also examined. In contrast to non-transformed normal cells, or transformed cells expressing other papillomavirus proteins, cells expressing E5 do not express MHC I on their surface, but retain it intracellularly, independently of the presence of other viral or cellular oncogenes, or of whether the cells are long-term transformants or acutely infected. We conclude that expression of E5 prevents expression of MHC I to the cell surface and causes its retention within the cell. In addition, lower amounts of total MHC I heavy chain and of heavy chain RNA are detected in E5-transformed cells than in control cells. As surface expression of another glycosylated membrane protein, the transferrin receptor, is not affected, it appears that E5 targets MHC I with at least a degree of specificity. In papillomavirus lesions this effect would have important implications for antigen presentation by, and immunosurveillance of, virally infected cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803468     DOI: 10.1038/sj.onc.1205008

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  A role for HPV16 E5 in cervical carcinogenesis.

Authors:  John P Maufort; Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  The canine papillomavirus e5 protein signals from the endoplasmic reticulum.

Authors:  Rachel Condjella; Xuefeng Liu; Frank Suprynowicz; Hang Yuan; Sawali Sudarshan; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

3.  A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours.

Authors:  Lies Bogaert; Andrew W Woodham; Diane M Da Silva; Ann Martens; Evelyne Meyer; W Martin Kast
Journal:  J Gen Virol       Date:  2015-06-04       Impact factor: 3.891

4.  Immunogenicity of bovine and leporine articular chondrocytes and meniscus cells.

Authors:  Daniel J Huey; Johannah Sanchez-Adams; Vincent P Willard; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2011-11-04       Impact factor: 3.845

Review 5.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

6.  CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.

Authors:  Shiho Miura; Kei Kawana; Danny J Schust; Tomoyuki Fujii; Terufumi Yokoyama; Yuki Iwasawa; Takeshi Nagamatsu; Katsuyuki Adachi; Ayako Tomio; Kensuke Tomio; Satoko Kojima; Toshiharu Yasugi; Shiro Kozuma; Yuji Taketani
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

7.  In planta production of a candidate vaccine against bovine papillomavirus type 1.

Authors:  Andrew J Love; Sean N Chapman; Slavica Matic; Emanuela Noris; George P Lomonossoff; Michael Taliansky
Journal:  Planta       Date:  2012-06-21       Impact factor: 4.116

8.  Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV).

Authors:  Marcia C M Guimarães; Christiane P Soares; Eduardo A Donadi; Sophie F M Derchain; Liliana A L A Andrade; Tarsia G A Silva; Marcela K Hassumi; Renata T Simões; Fabiana A Miranda; Régia C P Lira; Janaina Crispim; Edson G Soares
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479

9.  In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein.

Authors:  Risaku Fukumoto; Vibeke Andresen; Izabela Bialuk; Valentina Cecchinato; Jean-Claude Walser; Valerio W Valeri; Julie M Nauroth; Antoine Gessain; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

10.  Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.

Authors:  Z Q Yuan; L Nicolson; B Marchetti; E A Gault; M S Campo; L Nasir
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.